NEW YORK (GenomeWeb News) – Hologic said after the close of the market on Thursday that Jack Cumming is replacing Rob Cascella as president and CEO of the firm, effective immediately.

The company also pre-announced third-quarter revenues of $626 million and non-GAAP adjusted EPS of $.38.

In its announcement, Hologic said that Cascella is leaving the firm for "personal reasons" but will serve as an advisor to the company through November.

For Cumming, it will be his second go-round as CEO of the company. He previously headed Hologic between 2001 and 2009.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: mtDNA analysis give glimpse into decline of Neanderthals in Europe, and more.

The University of Arizona's Raina Maier writes that an understanding of the Earth's microbiome is needed.

The proposed Canadian budget emphasizes partnerships with industry, Nature News reports.

An Australian study of personalized medicine has run into problems as it recruits patients.

Apr
29
Sponsored by
Covance

This online seminar will review case studies demonstrating the clinical utility of CTCs and cfDNA to define and characterize a variety of dynamic genomic changes throughout the course of cancer detection and treatment.